Crowe BPG advises NORD Holding Small Cap in connection with its majority stake in MedXpert GmbH

Crowe BPG has advised the NORD Holding Small Cap Fund (“NSC”) on the acquisition of a majority stake in MedXpert GmbH (MedXpert), based in Eschbach (Baden-Württemberg), in the context of corporate succession. With a history of more than 50 years and assets under management of € 4.0 billion, NORD Holding is one of the leading private equity companies in Germany. NSC invests in established medium-sized companies that have a relevant market position or can achieve small cap through the support of NORD Holding.

MedXpert is a provider of implants and instruments for the bony thorax and has a broad product portfolio for the functional, dynamic and stable fixation of the bony thorax such as ribs or the sternum. The implants are used for rib and sternal trauma, for the correction of thoracic deformities and for large-scale reconstructions. MedXpert focuses on its patented and innovative stapling technology. As a unique selling point, the stapling method enables simple and stable application, makes implantation easier for the surgeon and contributes to improved patient comfort. MedXpert is known worldwide as “The Chest Wall Company” and is one of the few specialized suppliers in this segment.

MedXpert sells its products in over 40 countries worldwide. With a clear focus on innovation and product development as well as close cooperation with physicians and research institutions, MedXpert regularly sets new standards.

Based on the steadily increasing relevance and demand for surgical rib stabilization, the successful growth path to date is to be continued together with NORD Holding.

The Crowe BPG team (crowe-bpg.de), which was responsible for the financial due diligence and the economic contract consulting, consisted of Andreas Hoffmann, WP and Partner (overall management), Holger Redle, Senior Associate (Financial) and Henry Miller, Associate (Financial).

Source: Deal Advisors by Majunke